{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:30:32Z","timestamp":1791419432123,"version":"4.3.3"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:00:00Z","timestamp":1719014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), Joint British Diabetes Societies for Inpatient Care (JBDS), American Association of Clinical Endocrinology (AACE) and Diabetes Technology Society (DTS) convened a panel of internists and diabetologists to update the ADA consensus statement on hyperglycaemic crises in adults with diabetes, published in 2001 and last updated in 2009. The objective of this consensus report is to provide up-to-date knowledge about the epidemiology, pathophysiology, clinical presentation, and recommendations for the diagnosis, treatment and prevention of diabetic ketoacidosis (DKA)\u00a0and hyperglycaemic hyperosmolar state (HHS)\u00a0in adults. A systematic examination of publications since 2009 informed new recommendations. The target audience is the full spectrum of diabetes healthcare professionals and individuals with diabetes.<\/jats:p>","DOI":"10.1007\/s00125-024-06183-8","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:01:53Z","timestamp":1719014513000},"page":"1455-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Hyperglycaemic crises in adults with diabetes: a consensus report"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-5026","authenticated-orcid":false,"given":"Guillermo E.","family":"Umpierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9671-0063","authenticated-orcid":false,"given":"Georgia M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-4916","authenticated-orcid":false,"given":"Nuha A.","family":"ElSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6510-2097","authenticated-orcid":false,"given":"Gian Paolo","family":"Fadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9295-3225","authenticated-orcid":false,"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-8417","authenticated-orcid":false,"given":"Irl B.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1335-1857","authenticated-orcid":false,"given":"David C.","family":"Klonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2289-3183","authenticated-orcid":false,"given":"Rozalina G.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-0726","authenticated-orcid":false,"given":"Shivani","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3541-1486","authenticated-orcid":false,"given":"Robert A.","family":"Gabbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-5783","authenticated-orcid":false,"given":"Raveendhara R.","family":"Bannuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-9579","authenticated-orcid":false,"given":"Ketan K.","family":"Dhatariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,22]]},"reference":[{"key":"6183_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez G, Korytkowski M (2016) Diabetic emergencies \u2014 ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 12:222\u2013232. https:\/\/doi.org\/10.1038\/nrendo.2016.15","journal-title":"Nat Rev Endocrinol"},{"key":"6183_CR2","doi-asserted-by":"publisher","unstructured":"Dhatariya KK, Joint British Diabetes Societies for Inpatient Care (2022) The management of diabetic ketoacidosis in adults\u2014an updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med 39:e14788 https:\/\/doi.org\/10.1111\/dme.14788","DOI":"10.1111\/dme.14788"},{"key":"6183_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41572-020-0165-1","volume":"6","author":"KK Dhatariya","year":"2020","unstructured":"Dhatariya KK, Glaser NS, Codner E, Umpierrez GE (2020) Diabetic ketoacidosis. Nat Rev Dis Primers 6:40. https:\/\/doi.org\/10.1038\/s41572-020-0165-1","journal-title":"Nat Rev Dis Primers"},{"key":"6183_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.2337\/dc17-1583","volume":"41","author":"VW Zhong","year":"2018","unstructured":"Zhong VW, Juhaeri J, Mayer-Davis EJ (2018) Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998\u20132013: a retrospective cohort study. Diabetes Care 41:1870\u20131877. https:\/\/doi.org\/10.2337\/dc17-1583","journal-title":"Diabetes Care"},{"key":"6183_CR5","doi-asserted-by":"publisher","unstructured":"McCoy RG, Herrin J, Galindo RJ et al (2023) Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011\u20132020. Diabetes Care 46:e69\u2013e71. https:\/\/doi.org\/10.2337\/dc22-1673","DOI":"10.2337\/dc22-1673"},{"key":"6183_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.15585\/mmwr.mm6712a3","volume":"67","author":"SR Benoit","year":"2018","unstructured":"Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A (2018) Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality \u2014 United States, 2000\u20132014. MMWR Morb Mortal Wkly Rep 67:362\u2013365. https:\/\/doi.org\/10.15585\/mmwr.mm6712a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6183_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2337\/diacare.24.1.131","volume":"24","author":"AE Kitabchi","year":"2001","unstructured":"Kitabchi AE, Umpierrez GE, Murphy MB et al (2001) Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131\u2013153. https:\/\/doi.org\/10.2337\/diacare.24.1.131","journal-title":"Diabetes Care"},{"key":"6183_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S2213-8587(22)00272-8","volume":"10","author":"S Misra","year":"2022","unstructured":"Misra S (2022) Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain. Lancet Diabetes Endocrinol 10:763\u2013765. https:\/\/doi.org\/10.1016\/S2213-8587(22)00272-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6183_CR9","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.2337\/dc21-1318","volume":"44","author":"K Khunti","year":"2021","unstructured":"Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB (2021) COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care 44:2645\u20132655. https:\/\/doi.org\/10.2337\/dc21-1318","journal-title":"Diabetes Care"},{"key":"6183_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2337\/dc19-1168","volume":"43","author":"FJ Pasquel","year":"2020","unstructured":"Pasquel FJ, Tsegka K, Wang H et al (2020) Clinical outcomes in patients with isolated or combined diabetic ketoacidosis and hyperosmolar hyperglycemic state: a retrospective, hospital-based cohort study. Diabetes Care 43:349\u2013357. https:\/\/doi.org\/10.2337\/dc19-1168","journal-title":"Diabetes Care"},{"key":"6183_CR11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.2337\/diacare.24.11.1988","volume":"24","author":"American Diabetes Association","year":"2001","unstructured":"American Diabetes Association (2001) Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care 24:1988\u20131996. https:\/\/doi.org\/10.2337\/diacare.24.11.1988","journal-title":"Diabetes Care"},{"key":"6183_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2337\/dc09-9032","volume":"32","author":"AE Kitabchi","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009) Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32:1335\u20131343. https:\/\/doi.org\/10.2337\/dc09-9032","journal-title":"Diabetes Care"},{"key":"6183_CR13","doi-asserted-by":"publisher","unstructured":"Benoit SR, Hora I, Pasquel FJ, Gregg EW, Albright AL, Imperatore G. Trends in emergency department visits and inpatient admissions for hyperglycemic crises in adults with diabetes in the U.S., 2006\u20132015. Diabetes Care 2020;43:1057\u20131064 https:\/\/doi.org\/10.2337\/dc19-2449","DOI":"10.2337\/dc19-2449"},{"key":"6183_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4158\/EP161679.RA","volume":"23","author":"P Vellanki","year":"2017","unstructured":"Vellanki P, Umpierrez GE (2017) Diabetic ketoacidosis: a common debut of diabetes among African Americans with type 2 diabetes. Endocr Pract 23:971\u2013978. https:\/\/doi.org\/10.4158\/EP161679.RA","journal-title":"Endocr Pract"},{"key":"6183_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11892-018-1075-4","volume":"18","author":"HE Lebovitz","year":"2018","unstructured":"Lebovitz HE, Banerji MA (2018) Ketosis-prone diabetes (Flatbush diabetes): an emerging worldwide clinically important entity. Curr Diab Rep 18:120. https:\/\/doi.org\/10.1007\/s11892-018-1075-4","journal-title":"Curr Diab Rep"},{"key":"6183_CR16","doi-asserted-by":"publisher","first-page":"e2123471","DOI":"10.1001\/jamanetworkopen.2021.23471","volume":"4","author":"RG McCoy","year":"2021","unstructured":"McCoy RG, Galindo RJ, Swarna KS et al (2021) Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020. JAMA Netw Open 4:e2123471. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.23471","journal-title":"JAMA Netw Open"},{"key":"6183_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ecl.2022.06.005","volume":"52","author":"N Kikani","year":"2023","unstructured":"Kikani N, Balasubramanyam A (2023) Remission in ketosis-prone diabetes. Endocrinol Metab Clin North Am 52:165\u2013174. https:\/\/doi.org\/10.1016\/j.ecl.2022.06.005","journal-title":"Endocrinol Metab Clin North Am"},{"key":"6183_CR18","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.7417\/CT.2020.2189","volume":"170","author":"P Di Giovanni","year":"2020","unstructured":"Di Giovanni P, Meo F, Cedrone F et al (2020) Predictors and trend of ketoacidosis hospitalization rate in type 2 diabetes mellitus patients from 2006 to 2015 in Abruzzo region, Italy. Clin Ter 170:e53\u2013e58. https:\/\/doi.org\/10.7417\/CT.2020.2189","journal-title":"Clin Ter"},{"key":"6183_CR19","doi-asserted-by":"publisher","first-page":"e4353","DOI":"10.7759\/cureus.4353","volume":"11","author":"R Desai","year":"2019","unstructured":"Desai R, Singh S, Syed MH et al (2019) Temporal trends in the prevalence of diabetes decompensation (diabetic ketoacidosis and hyperosmolar hyperglycemic state) among adult patients hospitalized with diabetes mellitus: a nationwide analysis stratified by age, gender, and race. Cureus 11:e4353. https:\/\/doi.org\/10.7759\/cureus.4353","journal-title":"Cureus"},{"key":"6183_CR20","doi-asserted-by":"publisher","first-page":"109230","DOI":"10.1016\/j.diabres.2022.109230","volume":"185","author":"H Shaka","year":"2022","unstructured":"Shaka H, El-Amir Z, Wani F et al (2022) Hospitalizations and inpatient mortality for hyperosmolar hyperglycemic state over a decade. Diabetes Res Clin Pract 185:109230. https:\/\/doi.org\/10.1016\/j.diabres.2022.109230","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR21","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.2337\/dc21-0689","volume":"44","author":"JE O\u2019Reilly","year":"2021","unstructured":"O\u2019Reilly JE, Jeyam A, Caparrotta TM et al (2021) Rising rates and widening socioeconomic disparities in diabetic ketoacidosis in type 1 diabetes in Scotland: a nationwide retrospective cohort observational study. Diabetes Care 44:2010\u20132017. https:\/\/doi.org\/10.2337\/dc21-0689","journal-title":"Diabetes Care"},{"key":"6183_CR22","doi-asserted-by":"publisher","first-page":"e016587","DOI":"10.1136\/bmjopen-2017-016587","volume":"7","author":"S Fazeli Farsani","year":"2017","unstructured":"Fazeli Farsani S, Brodovicz K, Soleymanlou N, Marquard J, Wissinger E, Maiese BA (2017) Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. BMJ Open 7:e016587. https:\/\/doi.org\/10.1136\/bmjopen-2017-016587","journal-title":"BMJ Open"},{"key":"6183_CR23","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2337\/dc16-0668","volume":"39","author":"JA Mays","year":"2016","unstructured":"Mays JA, Jackson KL, Derby TA et al (2016) An evaluation of recurrent diabetic ketoacidosis, fragmentation of care, and mortality across Chicago, Illinois. Diabetes Care 39:1671\u20131676. https:\/\/doi.org\/10.2337\/dc16-0668","journal-title":"Diabetes Care"},{"key":"6183_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/dme.12875","volume":"33","author":"KK Dhatariya","year":"2016","unstructured":"Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G (2016) National survey of the management of diabetic ketoacidosis (DKA) in the UK in 2014. Diabet Med 33:252\u2013260. https:\/\/doi.org\/10.1111\/dme.12875","journal-title":"Diabet Med"},{"key":"6183_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4158\/EP-2018-0457","volume":"25","author":"CR Hurtado","year":"2019","unstructured":"Hurtado CR, Lemor A, Vallejo F et al (2019) Causes and predictors for 30-day re-admissions in adult patients with diabetic ketoacidosis in the United States: a nationwide analysis, 2010\u20132014. Endocr Pract 25:242\u2013253. https:\/\/doi.org\/10.4158\/EP-2018-0457","journal-title":"Endocr Pract"},{"key":"6183_CR26","doi-asserted-by":"publisher","unstructured":"McCoy RG, Herrin J, Lipska KJ, Shah ND (2018) Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes. J Diabetes Complications 32:693\u2013701. https:\/\/doi.org\/10.1016\/j.jdiacomp.2018.04.007","DOI":"10.1016\/j.jdiacomp.2018.04.007"},{"key":"6183_CR27","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1210\/clinem\/dgab372","volume":"106","author":"H Shaka","year":"2021","unstructured":"Shaka H, Aguilera M, Aucar M et al (2021) Rate and predictors of 30-day readmission following diabetic ketoacidosis in type 1 diabetes mellitus: a US analysis. J Clin Endocrinol Metab 106:2592\u20132599. https:\/\/doi.org\/10.1210\/clinem\/dgab372","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR28","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/dme.13427","volume":"34","author":"KK Dhatariya","year":"2017","unstructured":"Dhatariya KK, Skedgel C, Fordham R (2017) The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use. Diabet Med 34:1361\u20131366. https:\/\/doi.org\/10.1111\/dme.13427","journal-title":"Diabet Med"},{"key":"6183_CR29","doi-asserted-by":"publisher","unstructured":"Desai D, Mehta D, Mathias P, Menon G, Schubart UK (2018) Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care 41:1631\u20131638. https:\/\/doi.org\/10.2337\/dc17-1379","DOI":"10.2337\/dc17-1379"},{"key":"6183_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jcrc.2018.12.014","volume":"50","author":"SM Fernando","year":"2019","unstructured":"Fernando SM, Bagshaw SM, Rochwerg B et al (2019) Comparison of outcomes and costs between adult diabetic ketoacidosis patients admitted to the ICU and step-down unit. J Crit Care 50:257\u2013261. https:\/\/doi.org\/10.1016\/j.jcrc.2018.12.014","journal-title":"J Crit Care"},{"key":"6183_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40842-021-00127-6","volume":"7","author":"R Lyerla","year":"2021","unstructured":"Lyerla R, Johnson-Rabbett B, Shakally A, Magar R, Alameddine H, Fish L (2021) Recurrent DKA results in high societal costs - a retrospective study identifying social predictors of recurrence for potential future intervention. Clin Diabetes Endocrinol 7:13. https:\/\/doi.org\/10.1186\/s40842-021-00127-6","journal-title":"Clin Diabetes Endocrinol"},{"key":"6183_CR32","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1136\/jim-2021-001901","volume":"69","author":"H Shaka","year":"2021","unstructured":"Shaka H, Wani F, El-Amir Z et al (2021) Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with diabetic ketoacidosis: a review and a propensity-matched nationwide analysis. J Investig Med 69:1196\u20131200. https:\/\/doi.org\/10.1136\/jim-2021-001901","journal-title":"J Investig Med"},{"key":"6183_CR33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s11606-019-05006-6","volume":"34","author":"A Gaffney","year":"2019","unstructured":"Gaffney A, Christopher A, Katz A et al (2019) The incidence of diabetic ketoacidosis during \u201cemerging adulthood\u201d in the USA and Canada: a population-based study. J Gen Intern Med 34:1244\u20131250. https:\/\/doi.org\/10.1007\/s11606-019-05006-6","journal-title":"J Gen Intern Med"},{"key":"6183_CR34","doi-asserted-by":"publisher","unstructured":"McCoy RG, Herrin J, Galindo RJ et al (2023) All-cause mortality after hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011-2020. Diabetes Res Clin Pract 197:110263. https:\/\/doi.org\/10.1016\/j.diabres.2023.110263","DOI":"10.1016\/j.diabres.2023.110263"},{"key":"6183_CR35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/jdi.13475","volume":"12","author":"T Nishikawa","year":"2021","unstructured":"Nishikawa T, Kinoshita H, Ono K et al (2021) Clinical profiles of hyperglycemic crises: a single-center retrospective study from Japan. J Diabetes Investig 12:1359\u20131366. https:\/\/doi.org\/10.1111\/jdi.13475","journal-title":"J Diabetes Investig"},{"key":"6183_CR36","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.diabres.2020.108588","volume":"171","author":"Y Sato","year":"2021","unstructured":"Sato Y, Morita K, Okada A, Matsui H, Fushimi K, Yasunaga H (2021) Factors affecting in-hospital mortality of diabetic ketoacidosis patients: a retrospective cohort study. Diabetes Res Clin Pract 171:108588. https:\/\/doi.org\/10.1016\/j.diabres.2020.108588","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR37","doi-asserted-by":"publisher","first-page":"e14204","DOI":"10.1111\/ijcp.14204","volume":"75","author":"A Ibrahim","year":"2021","unstructured":"Ibrahim A, Bayramoglu B, Hokenek NM, Tekyol D (2021) Lactate clearance during the first 2 hours after hospital admission: a useful biomarker for predicting 30-day mortality in patients with diabetic ketoacidosis. Int J Clin Pract 75:e14204. https:\/\/doi.org\/10.1111\/ijcp.14204","journal-title":"Int J Clin Pract"},{"key":"6183_CR38","doi-asserted-by":"publisher","first-page":"e4789","DOI":"10.7759\/cureus.4789","volume":"11","author":"W Ahuja","year":"2019","unstructured":"Ahuja W, Kumar N, Kumar S, Rizwan A (2019) Precipitating risk factors, clinical presentation, and outcome of diabetic ketoacidosis in patients with type 1 diabetes. Cureus 11:e4789. https:\/\/doi.org\/10.7759\/cureus.4789","journal-title":"Cureus"},{"key":"6183_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diabres.2006.01.004","volume":"73","author":"ST Chung","year":"2006","unstructured":"Chung ST, Perue GG, Johnson A et al (2006) Predictors of hyperglycaemic crises and their associated mortality in Jamaica. Diabetes Res Clin Pract 73:184\u2013190. https:\/\/doi.org\/10.1016\/j.diabres.2006.01.004","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR40","first-page":"137","volume":"35","author":"MO Nkpozi","year":"2018","unstructured":"Nkpozi MO, Akhidue K, Unachukwu CN, Chinenye S, Chappjumbo AU (2018) Hyperglycaemic emergencies in a tertiary health facility in south-eastern Nigeria. West Afr J Med 35:137\u2013143","journal-title":"West Afr J Med"},{"key":"6183_CR41","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00592-022-01953-5","volume":"59","author":"JAD Shand","year":"2022","unstructured":"Shand JAD, Morrow P, Braatvedt G (2022) Mortality after discharge from hospital following an episode of diabetic ketoacidosis. Acta Diabetol 59:1485\u20131492. https:\/\/doi.org\/10.1007\/s00592-022-01953-5","journal-title":"Acta Diabetol"},{"key":"6183_CR42","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00125-016-4034-0","volume":"59","author":"FW Gibb","year":"2016","unstructured":"Gibb FW, Teoh WL, Graham J, Lockman KA (2016) Risk of death following admission to a UK hospital with diabetic ketoacidosis. Diabetologia 59:2082\u20132087. https:\/\/doi.org\/10.1007\/s00125-016-4034-0","journal-title":"Diabetologia"},{"key":"6183_CR43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.diabres.2011.06.018","volume":"94","author":"GP Fadini","year":"2011","unstructured":"Fadini GP, de Kreutzenberg SV, Rigato M et al (2011) Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract 94:172\u2013179. https:\/\/doi.org\/10.1016\/j.diabres.2011.06.018","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR44","doi-asserted-by":"publisher","first-page":"e3408","DOI":"10.1002\/dmrr.3408","volume":"37","author":"M Michaelis","year":"2021","unstructured":"Michaelis M, Shochat T, Shimon I, Akirov A (2021) Features and long-term outcomes of patients hospitalized for diabetic ketoacidosis. Diabetes Metab Res Rev 37:e3408. https:\/\/doi.org\/10.1002\/dmrr.3408","journal-title":"Diabetes Metab Res Rev"},{"key":"6183_CR45","doi-asserted-by":"publisher","unstructured":"Otieno CF, Kayima JK, Omonge EO, Oyoo GO (2005) Diabetic ketoacidosis: risk factors, mechanisms and management strategies in sub-Saharan Africa: a review. East Afr Med J 82(Suppl.):S197\u2013S203. https:\/\/doi.org\/10.4314\/eamj.v82i12.9382","DOI":"10.4314\/eamj.v82i12.9382"},{"key":"6183_CR46","doi-asserted-by":"publisher","first-page":"e000983","DOI":"10.1136\/bmjdrc-2019-000983","volume":"8","author":"TME Davis","year":"2020","unstructured":"Davis TME, Davis W (2020) Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase II. BMJ Open Diabetes Res Care 8:e000983. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000983","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6183_CR47","doi-asserted-by":"publisher","first-page":"107797","DOI":"10.1016\/j.diabres.2019.107797","volume":"155","author":"KK Dhatariya","year":"2019","unstructured":"Dhatariya KK (2019) Defining and characterising diabetic ketoacidosis in adults. Diabetes Res Clin Pract 155:107797. https:\/\/doi.org\/10.1016\/j.diabres.2019.107797","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR48","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2337\/dc11-0701","volume":"34","author":"L Randall","year":"2011","unstructured":"Randall L, Begovic J, Hudson M et al (2011) Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care 34:1891\u20131896. https:\/\/doi.org\/10.2337\/dc11-0701","journal-title":"Diabetes Care"},{"key":"6183_CR49","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.mcna.2016.12.011","volume":"101","author":"M Fayfman","year":"2017","unstructured":"Fayfman M, Pasquel FJ, Umpierrez GE (2017) Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am 101:587\u2013606. https:\/\/doi.org\/10.1016\/j.mcna.2016.12.011","journal-title":"Med Clin North Am"},{"key":"6183_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00000441-199311000-00004","volume":"306","author":"WD Paulson","year":"1993","unstructured":"Paulson WD, Gadallah MF (1993) Diagnosis of mixed acid-base disorders in diabetic ketoacidosis. Am J Med Sci 306:295\u2013300. https:\/\/doi.org\/10.1097\/00000441-199311000-00004","journal-title":"Am J Med Sci"},{"key":"6183_CR51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jcjd.2019.01.008","volume":"43","author":"S Del Degan","year":"2019","unstructured":"Del Degan S, Dub\u00e9 F, Gagnon C, Boulet G (2019) Risk factors for recurrent diabetic ketoacidosis in adults with type 1 diabetes. Can J Diabetes 43:472-476.e1. https:\/\/doi.org\/10.1016\/j.jcjd.2019.01.008","journal-title":"Can J Diabetes"},{"key":"6183_CR52","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(97)06234-X","volume":"350","author":"AD Morris","year":"1997","unstructured":"Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW (1997) Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 350:1505\u20131510. https:\/\/doi.org\/10.1016\/S0140-6736(97)06234-X","journal-title":"Lancet"},{"key":"6183_CR53","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0889-8529(05)70159-6","volume":"29","author":"MF Delaney","year":"2000","unstructured":"Delaney MF, Zisman A, Kettyle WM (2000) Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 29:683\u2013705. https:\/\/doi.org\/10.1016\/S0889-8529(05)70159-6","journal-title":"Endocrinol Metab Clin North Am"},{"key":"6183_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4158\/EP.13.1.22","volume":"13","author":"EA Nyenwe","year":"2007","unstructured":"Nyenwe EA, Loganathan RS, Blum S et al (2007) Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract 13:22\u201329. https:\/\/doi.org\/10.4158\/EP.13.1.22","journal-title":"Endocr Pract"},{"key":"6183_CR55","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ncpendmet0641","volume":"3","author":"SN Davis","year":"2007","unstructured":"Davis SN, Umpierrez GE (2007) Diabetic ketoacidosis in type 2 diabetes mellitus\u2013pathophysiology and clinical presentation. Nat Clin Pract Endocrinol Metab 3:730\u2013731. https:\/\/doi.org\/10.1038\/ncpendmet0641","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"6183_CR56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.diabres.2011.09.012","volume":"94","author":"EA Nyenwe","year":"2011","unstructured":"Nyenwe EA, Kitabchi AE (2011) Evidence-based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Res Clin Pract 94:340\u2013351. https:\/\/doi.org\/10.1016\/j.diabres.2011.09.012","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/archinte.1997.00440270117011","volume":"157","author":"GE Umpierrez","year":"1997","unstructured":"Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE (1997) Hyperglycemic crises in urban blacks. Arch Intern Med 157:669\u2013675. https:\/\/doi.org\/10.1001\/archinte.1997.00440270117011","journal-title":"Arch Intern Med"},{"key":"6183_CR58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1210\/clinem\/dgz003","volume":"105","author":"M Thomas","year":"2020","unstructured":"Thomas M, Harjutsalo V, Feodoroff M, Forsblom C, Gordin D, Groop PH (2020) The long-term incidence of hospitalization for ketoacidosis in adults with established T1D\u2014a prospective cohort study. J Clin Endocrinol Metab 105:231\u2013241. https:\/\/doi.org\/10.1210\/clinem\/dgz003","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR59","doi-asserted-by":"publisher","first-page":"e2143597","DOI":"10.1001\/jamanetworkopen.2021.43597","volume":"5","author":"SS Kurani","year":"2022","unstructured":"Kurani SS, Heien HC, Sangaralingham LR et al (2022) Association of area-level socioeconomic deprivation with hypoglycemic and hyperglycemic crises in US adults with diabetes. JAMA Netw Open 5:e2143597. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.43597","journal-title":"JAMA Netw Open"},{"key":"6183_CR60","doi-asserted-by":"publisher","first-page":"e2250602","DOI":"10.1001\/jamanetworkopen.2022.50602","volume":"6","author":"DH Jiang","year":"2023","unstructured":"Jiang DH, Herrin J, Van Houten HK, McCoy RG (2023) Evaluation of high-deductible health plans and acute glycemic complications among adults with diabetes. JAMA Netw Open 6:e2250602. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50602","journal-title":"JAMA Netw Open"},{"key":"6183_CR61","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.eclinm.2022.101759","volume":"55","author":"S Matthews","year":"2022","unstructured":"Matthews S, Coates MM, Bukhman A et al (2022) Health system capacity to manage diabetic ketoacidosis in nine low-income and lower-middle income countries: a cross-sectional analysis of nationally representative survey data. EClinicalMedicine 55:101759. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101759","journal-title":"EClinicalMedicine"},{"key":"6183_CR62","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/pedi.13386","volume":"23","author":"LA Reid","year":"2022","unstructured":"Reid LA, Mendoza JA, Merchant AT et al (2022) Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth-onset type 2 diabetes. Pediatr Diabetes 23:982\u2013990. https:\/\/doi.org\/10.1111\/pedi.13386","journal-title":"Pediatr Diabetes"},{"key":"6183_CR63","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.2337\/dc18-0657","volume":"41","author":"K Goueslard","year":"2018","unstructured":"Goueslard K, Petit JM, Cottenet J, Chauvet-Gelinier JC, Jollant F, Quantin C (2018) Increased risk of rehospitalization for acute diabetes complications and suicide attempts in patients with type 1 diabetes and comorbid schizophrenia. Diabetes Care 41:2316\u20132321. https:\/\/doi.org\/10.2337\/dc18-0657","journal-title":"Diabetes Care"},{"key":"6183_CR64","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/dme.13673","volume":"35","author":"HC Price","year":"2018","unstructured":"Price HC, Ismail K (2018) Royal College of Psychiatrists Liaison Faculty & Joint British Diabetes Societies (JBDS): guidelines for the management of diabetes in adults and children with psychiatric disorders in inpatient settings. Diabet Med 35:997\u20131004. https:\/\/doi.org\/10.1111\/dme.13673","journal-title":"Diabet Med"},{"key":"6183_CR65","first-page":"531","volume":"63","author":"E Brandstaetter","year":"2019","unstructured":"Brandstaetter E, Bartal C, Sagy I, Jotkowitz A, Barski L (2019) Recurrent diabetic ketoacidosis. Arch Endocrinol Metab 63:531\u2013535","journal-title":"Arch Endocrinol Metab"},{"key":"6183_CR66","doi-asserted-by":"publisher","unstructured":"Trief PM, Xing D, Foster NC et al (2014) T1D Exchange clinic network. Depression in adults in the T1D exchange clinic registry. Diabetes Care 37:1563\u20131572. https:\/\/doi.org\/10.2337\/dc13-1867","DOI":"10.2337\/dc13-1867"},{"key":"6183_CR67","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00125-020-05206-4","volume":"63","author":"JM Petit","year":"2020","unstructured":"Petit JM, Goueslard K, Chauvet-Gelinier JC et al (2020) Association between hospital admission for ketoacidosis and subsequent suicide attempt in young adults with type 1 diabetes. Diabetologia 63:1745\u20131752. https:\/\/doi.org\/10.1007\/s00125-020-05206-4","journal-title":"Diabetologia"},{"key":"6183_CR68","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/bmj.328.7442.741","volume":"328","author":"SE Roberts","year":"2004","unstructured":"Roberts SE, Goldacre MJ, Neil HAW (2004) Mortality in young people admitted to hospital for diabetes: database study. BMJ 328:741\u2013742. https:\/\/doi.org\/10.1136\/bmj.328.7442.741","journal-title":"BMJ"},{"key":"6183_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pcd.2012.11.002","volume":"7","author":"N Hermanns","year":"2013","unstructured":"Hermanns N, Caputo S, Dzida G, Khunti K, Meneghini LF, Snoek F (2013) Screening, evaluation and management of depression in people with diabetes in primary care. Prim Care Diabetes 7:1\u201310. https:\/\/doi.org\/10.1016\/j.pcd.2012.11.002","journal-title":"Prim Care Diabetes"},{"key":"6183_CR70","doi-asserted-by":"publisher","unstructured":"Fisher L, Polonsky W, Naranjo D, Strycker L, Hessler D A novel approach to understanding and assessing the emotional side of type 1 diabetes: the Type 1-Diabetes Distress Assessment System. Diabet Med 2024:e15282 https:\/\/doi.org\/10.1111\/dme.15282","DOI":"10.1111\/dme.15282"},{"key":"6183_CR71","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1007\/s00125-021-05413-7","volume":"64","author":"A Jeyam","year":"2021","unstructured":"Jeyam A, Gibb FW, McKnight JA et al (2021) Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland. Diabetologia 64:1320\u20131331. https:\/\/doi.org\/10.1007\/s00125-021-05413-7","journal-title":"Diabetologia"},{"key":"6183_CR72","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/dia.2020.0675","volume":"23","author":"T Biester","year":"2021","unstructured":"Biester T, Schwandt A, Heidtmann B et al (2021) Declining frequency of acute complications associated with tubeless insulin pump use: data from 2,911 patients in the German\/Austrian Diabetes Patienten Verlaufsdokumentation Registry. Diabetes Technol Ther 23:527\u2013536. https:\/\/doi.org\/10.1089\/dia.2020.0675","journal-title":"Diabetes Technol Ther"},{"key":"6183_CR73","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/pedi.13377","volume":"23","author":"JH Wers\u00e4ll","year":"2022","unstructured":"Wers\u00e4ll JH, Adolfsson P, Forsander G, Hanas R (2022) Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: a 2-year Swedish national survey of children and adolescents with type 1 diabetes. Pediatr Diabetes 23:1038\u20131044. https:\/\/doi.org\/10.1111\/pedi.13377","journal-title":"Pediatr Diabetes"},{"key":"6183_CR74","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1055\/a-0654-5134","volume":"128","author":"LC Giessmann","year":"2020","unstructured":"Giessmann LC, Kann PH (2020) Risk and relevance of insulin pump therapy in the aetiology of ketoacidosis in people with type 1 diabetes. Exp Clin Endocrinol Diabetes 128:745\u2013751. https:\/\/doi.org\/10.1055\/a-0654-5134","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"6183_CR75","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/dia.2021.0514","volume":"24","author":"GP Forlenza","year":"2022","unstructured":"Forlenza GP, Lal RA (2022) Current status and emerging options for automated insulin delivery systems. Diabetes Technol Ther 24:362\u2013371. https:\/\/doi.org\/10.1089\/dia.2021.0514","journal-title":"Diabetes Technol Ther"},{"key":"6183_CR76","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1080\/17434440.2021.1926984","volume":"18","author":"J McVean","year":"2021","unstructured":"McVean J, Miller J (2021) MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy. Expert Rev Med Devices 18:499\u2013504. https:\/\/doi.org\/10.1080\/17434440.2021.1926984","journal-title":"Expert Rev Med Devices"},{"key":"6183_CR77","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/dc23-0635","volume":"46","author":"TSJ Crabtree","year":"2023","unstructured":"Crabtree TSJ, Griffin TP, Yap YW et al (2023) Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study. Diabetes Care 46:1831\u20131838. https:\/\/doi.org\/10.2337\/dc23-0635","journal-title":"Diabetes Care"},{"key":"6183_CR78","doi-asserted-by":"publisher","first-page":"102389","DOI":"10.1016\/j.dsx.2022.102389","volume":"16","author":"F Khan","year":"2022","unstructured":"Khan F, Paladino L, Sinert R (2022) The impact of COVID-19 on diabetic ketoacidosis patients. Diabetes Metab Syndr 16:102389. https:\/\/doi.org\/10.1016\/j.dsx.2022.102389","journal-title":"Diabetes Metab Syndr"},{"key":"6183_CR79","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2213-8587(21)00208-4","volume":"9","author":"S Misra","year":"2021","unstructured":"Misra S, Barron E, Vamos E et al (2021) Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Lancet Diabetes Endocrinol 9:671\u2013680. https:\/\/doi.org\/10.1016\/S2213-8587(21)00208-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6183_CR80","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.2337\/dc22-0616","volume":"45","author":"OY Bello-Chavolla","year":"2022","unstructured":"Bello-Chavolla OY, Antonio-Villa NE, Ferm\u00edn-Mart\u00ednez CA et al (2022) Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017\u20132019 and 2020. Diabetes Care 45:2957\u20132966. https:\/\/doi.org\/10.2337\/dc22-0616","journal-title":"Diabetes Care"},{"key":"6183_CR81","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1210\/clinem\/dgac158","volume":"107","author":"AR Lavik","year":"2022","unstructured":"Lavik AR, Ebekozien O, Noor N et al (2022) Trends in type 1 diabetic ketoacidosis during COVID-19 surges at 7 US centers: highest burden on non-Hispanic Black patients. J Clin Endocrinol Metab 107:1948\u20131955","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.schres.2004.03.024","volume":"71","author":"H Jin","year":"2004","unstructured":"Jin H, Meyer JM, Jeste DV (2004) Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 71:195\u2013212. https:\/\/doi.org\/10.1016\/j.schres.2004.03.024","journal-title":"Schizophr Res"},{"key":"6183_CR83","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1365-2265.2011.04242.x","volume":"77","author":"KCJ Yuen","year":"2012","unstructured":"Yuen KCJ, McDaniel PA, Riddle MC (2012) Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg\/day) treatment: evidence for differing effects on insulin secretion and action. Clin Endocrinol 77:224\u2013232. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04242.x","journal-title":"Clin Endocrinol"},{"key":"6183_CR84","doi-asserted-by":"publisher","first-page":"e0231190","DOI":"10.1371\/journal.pone.0231190","volume":"19","author":"M Shah","year":"2020","unstructured":"Shah M, Adel MM, Tahsin B, Guerra Y, Fogelfeld L (2020) Effect of short-term prednisone on beta-cell function in subjects with type 2 diabetes mellitus and healthy subjects. PLoS One 19:e0231190. https:\/\/doi.org\/10.1371\/journal.pone.0231190","journal-title":"PLoS One"},{"key":"6183_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-013-2982-3","volume":"226","author":"MD Guenette","year":"2013","unstructured":"Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ (2013) Atypical antipsychotics and diabetic ketoacidosis: a review. Psychopharmacology 226:1\u201312. https:\/\/doi.org\/10.1007\/s00213-013-2982-3","journal-title":"Psychopharmacology"},{"key":"6183_CR86","doi-asserted-by":"publisher","first-page":"110776","DOI":"10.1016\/j.diabres.2023.110776","volume":"202","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Sharma R, Hamad L, Riebandt G, Attwood K (2023) Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy - a comprehensive cancer center experience. Diabetes Res Clin Pract 202:110776. https:\/\/doi.org\/10.1016\/j.diabres.2023.110776","journal-title":"Diabetes Res Clin Pract"},{"key":"6183_CR87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1210\/er.2018-00006","volume":"40","author":"LS Chang","year":"2019","unstructured":"Chang LS, Barroso-Sousa R, Tolaney SM, Hodi FS, Kaiser UB, Min L (2019) Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 40:17\u201365. https:\/\/doi.org\/10.1210\/er.2018-00006","journal-title":"Endocr Rev"},{"key":"6183_CR88","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/1753-0407.13215","volume":"13","author":"SR Tittel","year":"2021","unstructured":"Tittel SR, Laubner K, Schmid SM et al (2021) Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - a prospective, matched control study. J Diabetes 13:1007\u20131014. https:\/\/doi.org\/10.1111\/1753-0407.13215","journal-title":"J Diabetes"},{"key":"6183_CR89","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2337\/dc22-2202","volume":"46","author":"L Wu","year":"2023","unstructured":"Wu L, Tsang V, Menzies AM et al (2023) Risk factors and characteristics of checkpoint inhibitor-associated autoimmune diabetes mellitus (CIADM): a systematic review and delineation from type 1 diabetes. Diabetes Care 46:1292\u20131299. https:\/\/doi.org\/10.2337\/dc22-2202","journal-title":"Diabetes Care"},{"key":"6183_CR90","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2337\/dci19-0008","volume":"42","author":"JI Wolfsdorf","year":"2019","unstructured":"Wolfsdorf JI, Ratner RE (2019) SGLT inhibitors for type 1 diabetes: proceed with extreme caution. Diabetes Care 42:991\u2013993. https:\/\/doi.org\/10.2337\/dci19-0008","journal-title":"Diabetes Care"},{"key":"6183_CR91","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00125-017-4301-8","volume":"60","author":"GP Fadini","year":"2017","unstructured":"Fadini GP, Bonora BM, Avogaro A (2017) SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System. Diabetologia 60:1385\u20131389. https:\/\/doi.org\/10.1007\/s00125-017-4301-8","journal-title":"Diabetologia"},{"key":"6183_CR92","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s00125-022-05773-8","volume":"65","author":"E Marilly","year":"2022","unstructured":"Marilly E, Cottin J, Cabrera N et al (2022) SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits. Diabetologia 65:2000\u20132010. https:\/\/doi.org\/10.1007\/s00125-022-05773-8","journal-title":"Diabetologia"},{"key":"6183_CR93","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jcjd.2021.04.006","volume":"46","author":"M Colacci","year":"2022","unstructured":"Colacci M, Fralick J, Odutayo A, Fralick M (2022) Sodium-glucose cotransporter-2 inhibitors and risk of diabetic ketoacidosis among adults with type 2 diabetes: a systematic review and meta-analysis. Can J Diabetes 46:10-15.e2. https:\/\/doi.org\/10.1016\/j.jcjd.2021.04.006","journal-title":"Can J Diabetes"},{"key":"6183_CR94","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00228-020-03051-3","volume":"77","author":"AO Bamgboye","year":"2021","unstructured":"Bamgboye AO, Oni IO, Collier A (2021) Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review. Eur J Clin Pharmacol 77:651\u2013657. https:\/\/doi.org\/10.1007\/s00228-020-03051-3","journal-title":"Eur J Clin Pharmacol"},{"key":"6183_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12902-020-00659-5","volume":"20","author":"XY Wu","year":"2020","unstructured":"Wu XY, She DM, Wang F et al (2020) Clinical profiles, outcomes and risk factors among type 2 diabetic inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 6-year period. BMC Endocr Disord 20:182. https:\/\/doi.org\/10.1186\/s12902-020-00659-5","journal-title":"BMC Endocr Disord"},{"key":"6183_CR96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/dom.13012","volume":"20","author":"BM Bonora","year":"2018","unstructured":"Bonora BM, Avogaro A, Fadini GP (2018) Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: an updated review of the literature. Diabetes Obes Metab 20:25\u201333. https:\/\/doi.org\/10.1111\/dom.13012","journal-title":"Diabetes Obes Metab"},{"key":"6183_CR97","doi-asserted-by":"publisher","unstructured":"Blau JE, Tella SH, Taylor SI, Rother KI (2017) Ketoacidosis associated with SGLT2 inhibitor treatment: analysis of FAERS data. Diabetes Metab Res Rev 33. https:\/\/doi.org\/10.1002\/dmrr.2924","DOI":"10.1002\/dmrr.2924"},{"key":"6183_CR98","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM198409203111202","volume":"311","author":"PA Phillips","year":"1984","unstructured":"Phillips PA, Rolls BJ, Ledingham JGG et al (1984) Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 311:753\u2013759. https:\/\/doi.org\/10.1056\/NEJM198409203111202","journal-title":"N Engl J Med"},{"key":"6183_CR99","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2337\/diaspect.15.1.28","volume":"15","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez GE, Murphy MB, Kitabchi AE (2002) Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Diabetes Spectr 15:28\u201336. https:\/\/doi.org\/10.2337\/diaspect.15.1.28","journal-title":"Diabetes Spectr"},{"key":"6183_CR100","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2337\/diabetes.53.8.2079","volume":"53","author":"FB Stentz","year":"2004","unstructured":"Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE (2004) Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53:2079\u20132086. https:\/\/doi.org\/10.2337\/diabetes.53.8.2079","journal-title":"Diabetes"},{"key":"6183_CR101","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/bmj.2.5866.578","volume":"2","author":"JF Munro","year":"1973","unstructured":"Munro JF, Campbell IW, McCuish AC, Duncan LJ (1973) Euglycaemic diabetic ketoacidosis. BMJ 2:578\u2013580. https:\/\/doi.org\/10.1136\/bmj.2.5866.578","journal-title":"BMJ"},{"key":"6183_CR102","doi-asserted-by":"publisher","first-page":"e003666","DOI":"10.1136\/bmjdrc-2023-003666","volume":"11","author":"E Chow","year":"2023","unstructured":"Chow E, Clement S, Garg R (2023) Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care 11:e003666. https:\/\/doi.org\/10.1136\/bmjdrc-2023-003666","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6183_CR103","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajem.2021.02.015","volume":"44","author":"B Long","year":"2021","unstructured":"Long B, Lentz S, Koyfman A, Gottlieb M (2021) Euglycemic diabetic ketoacidosis: etiologies, evaluation, and management. Am J Emerg Med 44:157\u2013160. https:\/\/doi.org\/10.1016\/j.ajem.2021.02.015","journal-title":"Am J Emerg Med"},{"key":"6183_CR104","doi-asserted-by":"publisher","first-page":"514","DOI":"10.4239\/wjd.v12.i5.514","volume":"12","author":"P Nasa","year":"2021","unstructured":"Nasa P, Chaudhary S, Shrivastava PK, Singh A (2021) Euglycemic diabetic ketoacidosis: a missed diagnosis. World J Diabetes 12:514\u2013523. https:\/\/doi.org\/10.4239\/wjd.v12.i5.514","journal-title":"World J Diabetes"},{"key":"6183_CR105","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.mayocp.2019.06.009","volume":"94","author":"J Macfarlane","year":"2019","unstructured":"Macfarlane J, Dhatariya K (2019) Incidence of euglycemic diabetic ketoacidosis in adults with type 1 diabetes in the United Kingdom before the widespread use of sodium glucose cotransporter 2 inhibitors. Mayo Clin Proc 94:1909\u20131910. https:\/\/doi.org\/10.1016\/j.mayocp.2019.06.009","journal-title":"Mayo Clin Proc"},{"key":"6183_CR106","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00592-022-02015-6","volume":"60","author":"Z He","year":"2023","unstructured":"He Z, Lam K, Zhao W et al (2023) SGLT-2 inhibitors and euglycemic diabetic ketoacidosis\/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment. Acta Diabetol 60:401\u2013411. https:\/\/doi.org\/10.1007\/s00592-022-02015-6","journal-title":"Acta Diabetol"},{"key":"6183_CR107","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2337\/dc21-1584","volume":"45","author":"A Palanca","year":"2022","unstructured":"Palanca A, van Nes F, Pardo F, Ampudia Blasco FJ, Mathieu C (2022) Real-world evidence of efficacy and safety of SGLT2 inhibitors as adjunctive therapy in adults with type 1 diabetes: a European two-center experience. Diabetes Care 45:650\u2013658. https:\/\/doi.org\/10.2337\/dc21-1584","journal-title":"Diabetes Care"},{"key":"6183_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2337\/dc21-2279","volume":"45","author":"ES Kilpatrick","year":"2022","unstructured":"Kilpatrick ES, Butler AE, Ostlundh L, Atkin SL, Sacks DB (2022) Controversies around the measurement of blood ketones to diagnose and manage diabetic ketoacidosis. Diabetes Care 45:267\u2013272. https:\/\/doi.org\/10.2337\/dc21-2279","journal-title":"Diabetes Care"},{"key":"6183_CR109","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","volume":"15","author":"L Laffel","year":"1999","unstructured":"Laffel L (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15:412\u2013426. https:\/\/doi.org\/10.1002\/(SICI)1520-7560(199911\/12)15:6%3c412::AID-DMRR72%3e3.0.CO;2-8","journal-title":"Diabetes Metab Res Rev"},{"key":"6183_CR110","doi-asserted-by":"publisher","unstructured":"Wolfsdorf JI, Allgrove J, Craig ME et al (2014) ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes 15(Suppl 20):154\u2013179. https:\/\/doi.org\/10.1111\/pedi.12165","DOI":"10.1111\/pedi.12165"},{"key":"6183_CR111","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/19322968231152236","volume":"18","author":"J Huang","year":"2024","unstructured":"Huang J, Yeung AM, Bergenstal RM et al (2024) Update on measuring ketones. J Diabetes Sci Technol 18:714\u2013726. https:\/\/doi.org\/10.1177\/19322968231152236","journal-title":"J Diabetes Sci Technol"},{"key":"6183_CR112","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/ijerph13090837","volume":"13","author":"J Brooke","year":"2016","unstructured":"Brooke J, Stiell M, Ojo O (2016) Evaluation of the accuracy of capillary hydroxybutyrate measurement compared with other measurements in the diagnosis of diabetic ketoacidosis: a systematic review. Int J Environ Res Public Health 13:837. https:\/\/doi.org\/10.3390\/ijerph13090837","journal-title":"Int J Environ Res Public Health"},{"key":"6183_CR113","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jemermed.2022.12.023","volume":"64","author":"S Cao","year":"2023","unstructured":"Cao S, Cao S (2023) Diabetic ketoalkalosis: a common yet easily overlooked alkalemic variant of diabetic ketoacidosis associated with mixed acid-base disorders. J Emerg Med 64:282\u2013288. https:\/\/doi.org\/10.1016\/j.jemermed.2022.12.023","journal-title":"J Emerg Med"},{"key":"6183_CR114","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMra1207788","volume":"372","author":"KS Kamel","year":"2015","unstructured":"Kamel KS, Halperin ML (2015) Acid-base problems in diabetic ketoacidosis. N Engl J Med 372:546\u2013554. https:\/\/doi.org\/10.1056\/NEJMra1207788","journal-title":"N Engl J Med"},{"key":"6183_CR115","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0885066612467149","volume":"29","author":"S Basnet","year":"2014","unstructured":"Basnet S, Venepalli PK, Andoh J, Verhulst S, Koirala J (2014) Effect of normal saline and half normal saline on serum electrolytes during recovery phase of diabetic ketoacidosis. J Intensive Care Med 29:38\u201342. https:\/\/doi.org\/10.1177\/0885066612467149","journal-title":"J Intensive Care Med"},{"key":"6183_CR116","doi-asserted-by":"publisher","first-page":"e226417","DOI":"10.1001\/jamanetworkopen.2022.6417","volume":"5","author":"P Rao","year":"2022","unstructured":"Rao P, Jiang SF, Kipnis P et al (2022) Evaluation of outcomes following hospital-wide implementation of a subcutaneous insulin protocol for diabetic ketoacidosis. JAMA Netw Open 5:e226417. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.6417","journal-title":"JAMA Netw Open"},{"key":"6183_CR117","doi-asserted-by":"publisher","first-page":"e15005","DOI":"10.1111\/dme.15005","volume":"40","author":"OG Mustafa","year":"2023","unstructured":"Mustafa OG, Haq M, Dashora U, Castro E (2023) Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med 40:e15005. https:\/\/doi.org\/10.1111\/dme.15005","journal-title":"Diabet Med"},{"key":"6183_CR118","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1053\/jcrc.2002.33030","volume":"17","author":"G Umpierrez","year":"2002","unstructured":"Umpierrez G, Freire AX (2002) Abdominal pain in patients with hyperglycemic crises. J Crit Care 17:63\u201367. https:\/\/doi.org\/10.1053\/jcrc.2002.33030","journal-title":"J Crit Care"},{"key":"6183_CR119","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s11606-022-07993-5","volume":"38","author":"HJ Han","year":"2023","unstructured":"Han HJ, Cole AE, Verma A (2023) Euglycemic diabetic ketoacidosis caused by alcoholic pancreatitis and starvation ketosis. J Gen Intern Med 38:1299\u20131301. https:\/\/doi.org\/10.1007\/s11606-022-07993-5","journal-title":"J Gen Intern Med"},{"key":"6183_CR120","doi-asserted-by":"publisher","unstructured":"Chandrasekara H, Fernando P, Danjuma M, Jayawarna C (2014) Ketoacidosis is not always due to diabetes. BMJ Case Rep 2014:bcr2013203263. https:\/\/doi.org\/10.1136\/bcr-2013-203263","DOI":"10.1136\/bcr-2013-203263"},{"key":"6183_CR121","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.2337\/diacare.27.8.1873","volume":"27","author":"GE Umpierrez","year":"2004","unstructured":"Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE (2004) Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 27:1873\u20131878. https:\/\/doi.org\/10.2337\/diacare.27.8.1873","journal-title":"Diabetes Care"},{"key":"6183_CR122","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00000441-199311000-00003","volume":"306","author":"ME May","year":"1993","unstructured":"May ME, Young C, King J (1993) Resource utilization in treatment of diabetic ketoacidosis in adults. Am J Med Sci 306:287\u2013294. https:\/\/doi.org\/10.1097\/00000441-199311000-00003","journal-title":"Am J Med Sci"},{"key":"6183_CR123","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2337\/diacare.20.3.349","volume":"20","author":"KA Javor","year":"1997","unstructured":"Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM (1997) Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 20:349\u2013354. https:\/\/doi.org\/10.2337\/diacare.20.3.349","journal-title":"Diabetes Care"},{"key":"6183_CR124","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/pedi.12027","volume":"14","author":"NS Glaser","year":"2013","unstructured":"Glaser NS, Ghetti S, Casper TC, Dean JM (2013) Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial. Pediatr Diabetes 14:435\u2013446. https:\/\/doi.org\/10.1111\/pedi.12027","journal-title":"Pediatr Diabetes"},{"key":"6183_CR125","doi-asserted-by":"publisher","first-page":"e0613","DOI":"10.1097\/CCE.0000000000000613","volume":"4","author":"NA Alghamdi","year":"2022","unstructured":"Alghamdi NA, Major P, Chaudhuri D et al (2022) Saline compared to balanced crystalloid in patients with diabetic ketoacidosis: a systematic review and meta-analysis of randomized controlled trials. Crit Care Explor 4:e0613. https:\/\/doi.org\/10.1097\/CCE.0000000000000613","journal-title":"Crit Care Explor"},{"key":"6183_CR126","doi-asserted-by":"publisher","first-page":"e2024596","DOI":"10.1001\/jamanetworkopen.2020.24596","volume":"3","author":"WH Self","year":"2020","unstructured":"Self WH, Evans CS, Jenkins CA et al (2020) Clinical effects of balanced crystalloids vs saline in adults with diabetic ketoacidosis: a subgroup analysis of cluster randomized clinical trials. JAMA Netw Open 3:e2024596. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.24596","journal-title":"JAMA Netw Open"},{"key":"6183_CR127","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.hrtlng.2022.03.014","volume":"54","author":"JA Catahay","year":"2022","unstructured":"Catahay JA, Polintan ET, Casimiro M et al (2022) Balanced electrolyte solutions versus isotonic saline in adult patients with diabetic ketoacidosis: a systematic review and meta-analysis. Heart Lung 54:74\u201379. https:\/\/doi.org\/10.1016\/j.hrtlng.2022.03.014","journal-title":"Heart Lung"},{"key":"6183_CR128","doi-asserted-by":"publisher","first-page":"e21324","DOI":"10.7759\/cureus.21324","volume":"14","author":"A Jahangir","year":"2022","unstructured":"Jahangir A, Jahangir A, Siddiqui FS et al (2022) Normal saline versus low chloride solutions in treatment of diabetic ketoacidosis: a systematic review of clinical trials. Cureus 14:e21324. https:\/\/doi.org\/10.7759\/cureus.21324","journal-title":"Cureus"},{"key":"6183_CR129","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1097\/PEC.0000000000001550","volume":"37","author":"KR Bergmann","year":"2021","unstructured":"Bergmann KR, Abuzzahab MJ, Nowak J et al (2021) Resuscitation with Ringer\u2019s lactate compared with normal saline for pediatric diabetic ketoacidosis. Pediatr Emerg Care 37:e236\u2013e242. https:\/\/doi.org\/10.1097\/PEC.0000000000001550","journal-title":"Pediatr Emerg Care"},{"key":"6183_CR130","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.2337\/dc09-0169","volume":"32","author":"GE Umpierrez","year":"2009","unstructured":"Umpierrez GE, Jones S, Smiley D et al (2009) Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care 32:1164\u20131169. https:\/\/doi.org\/10.2337\/dc09-0169","journal-title":"Diabetes Care"},{"key":"6183_CR131","doi-asserted-by":"publisher","first-page":"e000763","DOI":"10.1136\/bmjdrc-2019-000763","volume":"8","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Pasquel FJ, Fayfman M et al (2020) Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis. BMJ Open Diabetes Res Care 8:e000763. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000763","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6183_CR132","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jemermed.2007.11.033","volume":"38","author":"N Goyal","year":"2010","unstructured":"Goyal N, Miller JB, Sankey SS, Mossallam U (2010) Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. J Emerg Med 38:422\u2013427. https:\/\/doi.org\/10.1016\/j.jemermed.2007.11.033","journal-title":"J Emerg Med"},{"key":"6183_CR133","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2147\/CPAA.S334119","volume":"13","author":"TR Anis","year":"2021","unstructured":"Anis TR, Boudreau M, Thornton T (2021) Comparing the efficacy of a nurse-driven and a physician-driven diabetic ketoacidosis (DKA) treatment protocol. Clin Pharmacol 13:197\u2013202. https:\/\/doi.org\/10.2147\/CPAA.S334119","journal-title":"Clin Pharmacol"},{"key":"6183_CR134","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/(SICI)1096-9136(199706)14:6<482::AID-DIA371>3.0.CO;2-A","volume":"14","author":"RK Singh","year":"1997","unstructured":"Singh RK, Perros P, Frier BM (1997) Hospital management of diabetic ketoacidosis: are clinical guidelines implemented effectively? Diabet Med 14:482\u2013486. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199706)14:6%3c482::AID-DIA371%3e3.0.CO;2-A","journal-title":"Diabet Med"},{"key":"6183_CR135","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/pedi.12462","volume":"18","author":"VS Harrison","year":"2017","unstructured":"Harrison VS, Rustico S, Palladino AA, Ferrara C, Hawkes CP (2017) Glargine co-administration with intravenous insulin in pediatric diabetic ketoacidosis is safe and facilitates transition to a subcutaneous regimen. Pediatr Diabetes 18:742\u2013748. https:\/\/doi.org\/10.1111\/pedi.12462","journal-title":"Pediatr Diabetes"},{"key":"6183_CR136","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/dom.14929","volume":"25","author":"K Thammakosol","year":"2023","unstructured":"Thammakosol K, Sriphrapradang C (2023) Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: a randomized controlled trial. Diabetes Obes Metab 25:815\u2013822. https:\/\/doi.org\/10.1111\/dom.14929","journal-title":"Diabetes Obes Metab"},{"key":"6183_CR137","doi-asserted-by":"publisher","first-page":"e030221191986","DOI":"10.2174\/1573399817666210303095633","volume":"17","author":"A Mohamed","year":"2021","unstructured":"Mohamed A, Ploetz J, Hamarshi MS (2021) Evaluation of early administration of insulin glargine in the acute management of diabetic ketoacidosis. Curr Diabetes Rev 17:e030221191986. https:\/\/doi.org\/10.2174\/1573399817666210303095633","journal-title":"Curr Diabetes Rev"},{"key":"6183_CR138","doi-asserted-by":"publisher","unstructured":"Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA (2016) Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev Issue 1, Art no.:CD011281. https:\/\/doi.org\/10.1002\/14651858.CD011281.pub2","DOI":"10.1002\/14651858.CD011281.pub2"},{"key":"6183_CR139","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1210\/jc.2012-1244","volume":"97","author":"E Hsia","year":"2012","unstructured":"Hsia E, Seggelke S, Gibbs J et al (2012) Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab 97:3132\u20133137. https:\/\/doi.org\/10.1210\/jc.2012-1244","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR140","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.amjmed.2004.05.010","volume":"117","author":"GE Umpierrez","year":"2004","unstructured":"Umpierrez GE, Latif K, Stoever J et al (2004) Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 117:291\u2013296. https:\/\/doi.org\/10.1016\/j.amjmed.2004.05.010","journal-title":"Am J Med"},{"key":"6183_CR141","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.jemermed.2023.06.004","volume":"65","author":"K Stuhr","year":"2023","unstructured":"Stuhr K, LeeMaster R, Hickman AW, Reachi B, Pace W, Meek C (2023) Subcutaneous insulin versus traditional intravenous insulin infusion in treatment of mild to moderate diabetic ketoacidosis. J Emerg Med 65:e221\u2013e228. https:\/\/doi.org\/10.1016\/j.jemermed.2023.06.004","journal-title":"J Emerg Med"},{"key":"6183_CR142","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4103\/0253-7613.83109","volume":"43","author":"R Karoli","year":"2011","unstructured":"Karoli R, Fatima J, Salman T, Sandhu S, Shankar R (2011) Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs. Indian J Pharmacol 43:398\u2013401. https:\/\/doi.org\/10.4103\/0253-7613.83109","journal-title":"Indian J Pharmacol"},{"key":"6183_CR143","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7326\/0003-4819-84-6-633","volume":"84","author":"AE Kitabchi","year":"1976","unstructured":"Kitabchi AE, Ayyagari V, Guerra SM (1976) The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med 84:633\u2013638. https:\/\/doi.org\/10.7326\/0003-4819-84-6-633","journal-title":"Ann Intern Med"},{"key":"6183_CR144","doi-asserted-by":"publisher","unstructured":"ElSayed NA, Aleppo G, Aroda VR et al (2024) 16. Diabetes care in the hospital: Standards of Care in Diabetes\u20142024. Diabetes Care 47(Suppl 1):S295\u2013S306. https:\/\/doi.org\/10.2337\/dc24-S016","DOI":"10.2337\/dc24-S016"},{"key":"6183_CR145","doi-asserted-by":"publisher","unstructured":"Arora S, Cheng D, Wyler B, Menchine M (2012) Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med 30:481\u2013484. https:\/\/doi.org\/10.1016\/j.ajem.2011.01.002","DOI":"10.1016\/j.ajem.2011.01.002"},{"key":"6183_CR146","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1681\/ASN.2017111163","volume":"29","author":"AN Harris","year":"2018","unstructured":"Harris AN, Grimm PR, Lee HW et al (2018) Mechanism of hyperkalemia-induced metabolic acidosis. J Am Soc Nephrol 29:1411\u20131425. https:\/\/doi.org\/10.1681\/ASN.2017111163","journal-title":"J Am Soc Nephrol"},{"key":"6183_CR147","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4158\/EP.11.5.331","volume":"11","author":"K Murthy","year":"2005","unstructured":"Murthy K, Harrington JT, Siegel RD (2005) Profound hypokalemia in diabetic ketoacidosis: a therapeutic challenge. Endocr Pract 11:331\u2013334. https:\/\/doi.org\/10.4158\/EP.11.5.331","journal-title":"Endocr Pract"},{"key":"6183_CR148","doi-asserted-by":"publisher","first-page":"416","DOI":"10.20452\/pamw.4293","volume":"128","author":"A Cieluch","year":"2018","unstructured":"Cieluch A, Uruska A, Falkowski B et al (2018) Nonadherence to potassium replacement protocol leads to prolonged management of diabetic ketoacidosis. Pol Arch Intern Med 128:416\u2013420. https:\/\/doi.org\/10.20452\/pamw.4293","journal-title":"Pol Arch Intern Med"},{"key":"6183_CR149","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2110-5820-1-23","volume":"1","author":"HR Chua","year":"2011","unstructured":"Chua HR, Schneider A, Bellomo R (2011) Bicarbonate in diabetic ketoacidosis - a systematic review. Ann Intensive Care 1:23. https:\/\/doi.org\/10.1186\/2110-5820-1-23","journal-title":"Ann Intensive Care"},{"key":"6183_CR150","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1056\/NEJM200101253440404","volume":"344","author":"N Glaser","year":"2001","unstructured":"Glaser N, Barnett P, McCaslin I et al (2001) Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 344:264\u2013269. https:\/\/doi.org\/10.1056\/NEJM200101253440404","journal-title":"N Engl J Med"},{"key":"6183_CR151","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/DMSO.S13476","volume":"3","author":"J Ditzel","year":"2010","unstructured":"Ditzel J, Lervang HH (2010) Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis. Diabetes Metab Syndr Obes 3:319\u2013324. https:\/\/doi.org\/10.2147\/DMSO.S13476","journal-title":"Diabetes Metab Syndr Obes"},{"key":"6183_CR152","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1210\/jcem-57-1-177","volume":"57","author":"JN Fisher","year":"1983","unstructured":"Fisher JN, Kitabchi AE (1983) A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab 57:177\u2013180. https:\/\/doi.org\/10.1210\/jcem-57-1-177","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR153","doi-asserted-by":"publisher","first-page":"e000621","DOI":"10.1136\/bmjdrc-2018-000621","volume":"7","author":"E Everett","year":"2019","unstructured":"Everett E, Mathioudakis NN (2019) Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database. BMJ Open Diabetes Res Care 7:e000621. https:\/\/doi.org\/10.1136\/bmjdrc-2018-000621","journal-title":"BMJ Open Diabetes Res Care"},{"key":"6183_CR154","unstructured":"Gosmanov AR, Gosmanova EO, Kitabchi AE (2000) Hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. In: Feingold KR, Anawalt B, Blackman MR et al (eds). Endotext. MDText.com, Inc., South Dartmouth, MA. Available from www.ncbi.nlm.nih.gov\/books\/NBK279052\/. Accessed: 28 September 2023"},{"key":"6183_CR155","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.2337\/dc13-2232","volume":"37","author":"MA Harris","year":"2014","unstructured":"Harris MA, Wagner DV, Heywood M, Hoehn D, Bahia H, Spiro K (2014) Youth repeatedly hospitalized for DKA: proof of concept for novel interventions in children\u2019s healthcare (NICH). Diabetes Care 37:e125\u2013e126. https:\/\/doi.org\/10.2337\/dc13-2232","journal-title":"Diabetes Care"},{"key":"6183_CR156","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S2213-8587(20)30042-5","volume":"8","author":"D Ehrmann","year":"2020","unstructured":"Ehrmann D, Kulzer B, Roos T, Haak T, Al-Khatib M, Hermanns N (2020) Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes. Lancet Diabetes Endocrinol 8:436\u2013446. https:\/\/doi.org\/10.1016\/S2213-8587(20)30042-5","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6183_CR157","doi-asserted-by":"publisher","first-page":"e30631","DOI":"10.7759\/cureus.30631","volume":"14","author":"Z Tekin","year":"2022","unstructured":"Tekin Z, Saygili M (2022) The association between Medicaid expansion and diabetic ketoacidosis hospitalizations. Cureus 14:e30631. https:\/\/doi.org\/10.7759\/cureus.30631","journal-title":"Cureus"},{"key":"6183_CR158","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/dme.12441","volume":"31","author":"J Elliott","year":"2014","unstructured":"Elliott J, Jacques RM, Kruger J et al (2014) Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with type 1 diabetes. Diabet Med 31:847\u2013853. https:\/\/doi.org\/10.1111\/dme.12441","journal-title":"Diabet Med"},{"key":"6183_CR159","first-page":"34","volume":"133","author":"JH Lee","year":"2020","unstructured":"Lee JH, Orr-Walker BJ (2020) Diabetic ketoacidosis admissions at Middlemore Hospital: observational study of cause and patient demographics. N Z Med J 133:34\u201340","journal-title":"N Z Med J"},{"key":"6183_CR160","doi-asserted-by":"publisher","first-page":"e14743","DOI":"10.1111\/dme.14743","volume":"39","author":"C Diguisto","year":"2022","unstructured":"Diguisto C, Strachan MWJ, Churchill D, Ayman G, Knight M (2022) A study of diabetic ketoacidosis in the pregnant population in the United Kingdom: investigating the incidence, aetiology, management and outcomes. Diabet Med 39:e14743. https:\/\/doi.org\/10.1111\/dme.14743","journal-title":"Diabet Med"},{"key":"6183_CR161","doi-asserted-by":"publisher","unstructured":"Albanese-O\u2019Neill A, Wu M, Miller KM, Jacobsen L, Haller MJ (2017) Poor adherence to ketone testing in patients with type 1 diabetes. Diabetes Care 40:e38\u2013e39 https:\/\/doi.org\/10.2337\/dc16-2620","DOI":"10.2337\/dc16-2620"},{"key":"6183_CR162","doi-asserted-by":"publisher","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A et al The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2021;64:2609\u20132652. https:\/\/doi.org\/10.1007\/s00125-021-05568-3","DOI":"10.1007\/s00125-021-05568-3"},{"key":"6183_CR163","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/dia.2022.0085","volume":"24","author":"JP Riveline","year":"2022","unstructured":"Riveline JP, Roussel R, Vicaut E et al (2022) Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2 years after initiation: extended outcomes from the RELIEF study. Diabetes Technol Ther 24:611\u2013618. https:\/\/doi.org\/10.1089\/dia.2022.0085","journal-title":"Diabetes Technol Ther"},{"key":"6183_CR164","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2337\/dc20-1690","volume":"44","author":"R Roussel","year":"2021","unstructured":"Roussel R, Riveline JP, Vicaut E et al (2021) Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study. Diabetes Care 44:1368\u20131376. https:\/\/doi.org\/10.2337\/dc20-1690","journal-title":"Diabetes Care"},{"key":"6183_CR165","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1177\/19322968231191104","volume":"17","author":"EK Spanakis","year":"2023","unstructured":"Spanakis EK, Cook CB, Kulasa K et al (2023) A consensus statement for continuous glucose monitoring metrics for inpatient clinical trials. J Diabetes Sci Technol 17:1527\u20131552. https:\/\/doi.org\/10.1177\/19322968231191104","journal-title":"J Diabetes Sci Technol"},{"key":"6183_CR166","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jcjd.2018.11.003","volume":"43","author":"BP Galm","year":"2019","unstructured":"Galm BP, Bagshaw SM, Senior PA (2019) Acute management of diabetic ketoacidosis in adults at 3 teaching hospitals in Canada: a multicentre, retrospective cohort study. Can J Diabetes 43:309-315.e2. https:\/\/doi.org\/10.1016\/j.jcjd.2018.11.003","journal-title":"Can J Diabetes"},{"key":"6183_CR167","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/19322968231200847","volume":"18","author":"T Tian","year":"2024","unstructured":"Tian T, Aaron RE, Seley JJ et al (2024) Use of continuous glucose monitors upon hospital discharge of people with diabetes: promise, barriers, and opportunity. J Diabetes Sci Technol 18:207\u2013214. https:\/\/doi.org\/10.1177\/19322968231200847","journal-title":"J Diabetes Sci Technol"},{"key":"6183_CR168","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/19322968211042656","volume":"16","author":"KT Nguyen","year":"2022","unstructured":"Nguyen KT, Xu NY, Zhang JY et al (2022) Continuous ketone monitoring consensus report 2021. J Diabetes Sci Technol 16:689\u2013715. https:\/\/doi.org\/10.1177\/19322968211042656","journal-title":"J Diabetes Sci Technol"},{"key":"6183_CR169","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/imj.15214","volume":"52","author":"PS Hamblin","year":"2022","unstructured":"Hamblin PS, Abdul-Wahab AL, Xu SFB, Steele CE, Vogrin S (2022) Diabetic ketoacidosis: a canary in the mine for mental health disorders? Intern Med J 52:1002\u20131008. https:\/\/doi.org\/10.1111\/imj.15214","journal-title":"Intern Med J"},{"key":"6183_CR170","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.7326\/M22-2477","volume":"175","author":"A Gaffney","year":"2022","unstructured":"Gaffney A, Himmelstein DU, Woolhandler S (2022) Prevalence and correlates of patient rationing of insulin in the United States: a national survey. Ann Intern Med 175:1623\u20131626. https:\/\/doi.org\/10.7326\/M22-2477","journal-title":"Ann Intern Med"},{"key":"6183_CR171","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1001\/jama.2023.5747","volume":"329","author":"M Fang","year":"2023","unstructured":"Fang M, Selvin E (2023) Cost-related insulin rationing in US adults younger than 65 years with diabetes. JAMA 329:1700\u20131702. https:\/\/doi.org\/10.1001\/jama.2023.5747","journal-title":"JAMA"},{"key":"6183_CR172","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.2337\/dc21-0555","volume":"44","author":"ASY Nip","year":"2021","unstructured":"Nip ASY, Lodish M (2021) Trend of diabetes-related hospital admissions during the transition period from adolescence to adulthood in the state of California. Diabetes Care 44:2723\u20132728. https:\/\/doi.org\/10.2337\/dc21-0555","journal-title":"Diabetes Care"},{"key":"6183_CR173","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.2337\/dc20-3113","volume":"44","author":"A Rewers","year":"2021","unstructured":"Rewers A, Kuppermann N, Stoner MJ et al (2021) Effects of fluid rehydration strategy on correction of acidosis and electrolyte abnormalities in children with diabetic ketoacidosis. Diabetes Care 44:2061\u20132068. https:\/\/doi.org\/10.2337\/dc20-3113","journal-title":"Diabetes Care"},{"key":"6183_CR174","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.ajem.2010.02.004","volume":"29","author":"SA Mahler","year":"2011","unstructured":"Mahler SA, Conrad SA, Wang H, Arnold TC (2011) Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 29:670\u2013674. https:\/\/doi.org\/10.1016\/j.ajem.2010.02.004","journal-title":"Am J Emerg Med"},{"key":"6183_CR175","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/jpm12020302","volume":"12","author":"WT Wei","year":"2022","unstructured":"Wei WT, Lin SM, Hsu JY et al (2022) Association between hyperosmolar hyperglycemic state and venous thromboembolism in diabetes patients: a nationwide analysis in Taiwan. J Pers Med 12:302. https:\/\/doi.org\/10.3390\/jpm12020302","journal-title":"J Pers Med"},{"key":"6183_CR176","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/CH-200957","volume":"77","author":"S Pillai","year":"2021","unstructured":"Pillai S, Davies G, Lawrence M et al (2021) The effect of diabetic ketoacidosis (DKA) and its treatment on clot microstructure: are they thrombogenic? Clin Hemorheol Microcirc 77:183\u2013194","journal-title":"Clin Hemorheol Microcirc"},{"key":"6183_CR177","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/1753-0407.12448","volume":"9","author":"K Siwakoti","year":"2017","unstructured":"Siwakoti K, Giri S, Kadaria D (2017) Cerebral edema among adults with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome: incidence, characteristics, and outcomes. J Diabetes 9:208\u2013209. https:\/\/doi.org\/10.1111\/1753-0407.12448","journal-title":"J Diabetes"},{"key":"6183_CR178","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40842-020-00111-6","volume":"6","author":"K Kusumoto","year":"2020","unstructured":"Kusumoto K, Koriyama N, Kojima N, Ikeda M, Nishio Y (2020) Central pontine myelinolysis during treatment of hyperglycemic hyperosmolar syndrome: a case report. Clin Diabetes Endocrinol 6:23. https:\/\/doi.org\/10.1186\/s40842-020-00111-6","journal-title":"Clin Diabetes Endocrinol"},{"key":"6183_CR179","doi-asserted-by":"publisher","first-page":"e110925","DOI":"10.1371\/journal.pone.0110925","volume":"9","author":"JC Orban","year":"2014","unstructured":"Orban JC, Maizi\u00e8re EM, Ghaddab A, Van Obberghen E, Ichai C (2014) Incidence and characteristics of acute kidney injury in severe diabetic ketoacidosis. PLoS One 9:e110925. https:\/\/doi.org\/10.1371\/journal.pone.0110925","journal-title":"PLoS One"},{"key":"6183_CR180","doi-asserted-by":"publisher","first-page":"e13647","DOI":"10.1097\/MD.0000000000013647","volume":"97","author":"IW Chen","year":"2018","unstructured":"Chen IW, Lin CW (2018) Improvement in renal prognosis with prompt hemodialysis in hyperosmolar hyperglycemic state-related rhabdomyolysis: a case report. Medicine 97:e13647. https:\/\/doi.org\/10.1097\/MD.0000000000013647","journal-title":"Medicine"},{"key":"6183_CR181","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/jgs.16376","volume":"68","author":"D Schwarzfuchs","year":"2020","unstructured":"Schwarzfuchs D, Rabaev E, Sagy I et al (2020) Clinical and epidemiological characteristics of diabetic ketoacidosis in older adults. J Am Geriatr Soc 68:1256\u20131261. https:\/\/doi.org\/10.1111\/jgs.16376","journal-title":"J Am Geriatr Soc"},{"key":"6183_CR182","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.2337\/dci22-0039","volume":"45","author":"K Dhatariya","year":"2022","unstructured":"Dhatariya K (2022) Initiation and continuation of sodium-glucose cotransporter 2 inhibitors in hospital inpatients: ready for prime time? Diabetes Care 45:2806\u20132807. https:\/\/doi.org\/10.2337\/dci22-0039","journal-title":"Diabetes Care"},{"key":"6183_CR183","doi-asserted-by":"publisher","first-page":"e2673","DOI":"10.1210\/clinem\/dgab126","volume":"106","author":"RJ Galindo","year":"2021","unstructured":"Galindo RJ, Pasquel FJ, Vellanki P et al (2021) Biochemical parameters of diabetes ketoacidosis in patients with end-stage kidney disease and preserved renal function. J Clin Endocrinol Metab 106:e2673\u2013e2679. https:\/\/doi.org\/10.1210\/clinem\/dgab126","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR184","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1210\/clinem\/dgac464","volume":"107","author":"M Dhanasekaran","year":"2022","unstructured":"Dhanasekaran M, Mohan S, Erickson D et al (2022) Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes. J Clin Endocrinol Metab 107:3137\u20133143. https:\/\/doi.org\/10.1210\/clinem\/dgac464","journal-title":"J Clin Endocrinol Metab"},{"key":"6183_CR185","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-8587(22)00246-7","volume":"10","author":"NH Birkebaek","year":"2022","unstructured":"Birkebaek NH, Kamrath C, Grimsmann JM et al (2022) Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries. Lancet Diabetes Endocrinol 10:786\u2013794. https:\/\/doi.org\/10.1016\/S2213-8587(22)00246-7","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06183-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-024-06183-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06183-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:48:11Z","timestamp":1724453291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-024-06183-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,22]]},"references-count":185,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["6183"],"URL":"https:\/\/doi.org\/10.1007\/s00125-024-06183-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,22]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors thank R. Aaron and T. Tian (Diabetes Technology Society, Burlingame, CA, USA) for their editing assistance and M. Bonar (Leicester Diabetes Centre, Leicester, UK) for figure design.\u00a0Parts of this work were presented at: the 59th EASD Annual Meeting, Hamburg, Germany, 2\u20136 October 2023; the AACE Annual Meeting, New Orleans, LA, USA, 9\u201311 May 2024; and the ADA 84th Scientific Sessions, Orlando, FL, USA, 21\u201324 June 2024.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Acknowledgements"}},{"value":"GEU is supported by research grants from the National Institutes of Health (NIH) (NATS UL 3UL1TR002378-05S2) from the Clinical and Translational Science Award programme and from the NIH and National Center for Research Resources (NIH\/National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK] 2P30DK111024-06) and has served as a member of advisory boards for Dexcom and GlyCare. GMD is supported by a research grant from NIH\/NIDDK Career Development Award K23DK122199, has received research support from Insulet and has consulted for Medscape. GPF has received honoraria and consultancy and lecture fees from Abbott, AstraZeneca, Boehringer Ingelheim, Lilly, MSD, Novo Nordisk, Mundipharma, Sanofi, Takeda and Servier. RJG is supported by the NIDDK of the NIH under award numbers P30DK111024-08, 1K23DK123384 and 1R03DK138255. RJG has also received research support (to Emory University, Atlanta, GA, USA) for studies from Novo Nordisk, Dexcom and Eli Lilly and consulting\/advisory or honoraria\/lecture fees from Abbott Diabetes, Dexcom, Eli Lilly, Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Medtronic, and Bayer outside of this work. IBH has received research support from the NIH, Dexcom and MannKind and serves as consultant for Abbott Diabetes Care, Embecta and Hagar. DCK is a consultant for Afon, Atropos Health, GlucoTrack, Lifecare, Nevro, Novo Nordisk, Samsung and Thirdwayv. RGM is supported by the NIDDK of the NIH (R03DK127010 and R01DK135515), the National Institute on Aging of the NIH (R01AG079113), the Patient-Centered Outcomes Research Institute (DB-2020C2-20306), and the American Diabetes Association. RGM also serves as a consultant to EmmiEducation (Wolters Kluwer) on developing patient education materials related to diabetes and to Yale New Haven Health System\u2019s Center for Outcomes Research and Evaluation on developing quality measures related to diabetes. SM holds a personal award from the Wellcome Trust Clinical Career Development Scheme (223024\/Z\/21\/Z) and is supported by the National Institute for Health Research Imperial Biomedical Research Centre. SM also reports an investigator-initiated grant from Dexcom and has received speaker fees (donated to the institution) from Sanofi and Lilly. RAG has served as a consultant to Lark, Vida and Sweetch. RRB and NAE declare that there are no relationships or activities that might bias, or be perceived to bias, their work. KKD has received honoraria for travel, advisory boards and speaker fees from Abbott Diabetes, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lily, Menarini and Sanofi Diabetes. No other potential conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}}]}}